Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Vinnard

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 4, 2019
Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitisAlyssa Mezochow, Kiran T Thakur, Isaac Zentner, et al.
Frontiers in Microbiology|December 8, 2018
Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?Christopher Vinnard, Alyssa Mezochow, Hannah Oakland, et al.
Emerging Infectious Diseases|March 12, 2011
Isoniazid-resistant tuberculous meningitis, United States, 1993-2005Christopher Vinnard, Carla A Winston, E Paul Wileyto, et al.
Mbio|April 18, 2019
Adipose Tissue Regulates Pulmonary Pathology during TB InfectionJaneesh Plakkal Ayyappan, Usha Ganapathi, Kezia Lizardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort StudyChristopher Vinnard, Liza King, Sonal Munsiff, et al.
Tuberculosis Research and Treatment|February 13, 2018
A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients without Tuberculosis Infection: A Short ReportChristopher Vinnard, Isabel Manley, Brittney Scott, et al.
Journal of Medical Economics|May 17, 2019
Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung diseaseTheodore K Marras, Mehdi Mirsaeidi, Christopher Vinnard, et al.
Population Health Management|November 2, 2012
Effectiveness of interventions in reducing antibiotic use for upper respiratory infections in ambulatory care practicesChristopher Vinnard, Darren R Linkin, A Russell Localio, et al.
International Journal of Environmental Research and Public Health|November 6, 2019
Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung DiseaseAashka Parikh, Christopher Vinnard, Nicole Fahrenfeld, et al.
Tuberculosis (Edinburgh, Scotland)|November 14, 2022
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations studyKrina Mehta, Navaneeth Narayanan, Scott K Heysell, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 4, 2019
Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitisAlyssa Mezochow, Kiran T Thakur, Isaac Zentner, et al.
Frontiers in Microbiology|December 8, 2018
Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?Christopher Vinnard, Alyssa Mezochow, Hannah Oakland, et al.
Emerging Infectious Diseases|March 12, 2011
Isoniazid-resistant tuberculous meningitis, United States, 1993-2005Christopher Vinnard, Carla A Winston, E Paul Wileyto, et al.
Mbio|April 18, 2019
Adipose Tissue Regulates Pulmonary Pathology during TB InfectionJaneesh Plakkal Ayyappan, Usha Ganapathi, Kezia Lizardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort StudyChristopher Vinnard, Liza King, Sonal Munsiff, et al.
Tuberculosis Research and Treatment|February 13, 2018
A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients without Tuberculosis Infection: A Short ReportChristopher Vinnard, Isabel Manley, Brittney Scott, et al.
Journal of Medical Economics|May 17, 2019
Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung diseaseTheodore K Marras, Mehdi Mirsaeidi, Christopher Vinnard, et al.
Population Health Management|November 2, 2012
Effectiveness of interventions in reducing antibiotic use for upper respiratory infections in ambulatory care practicesChristopher Vinnard, Darren R Linkin, A Russell Localio, et al.
International Journal of Environmental Research and Public Health|November 6, 2019
Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung DiseaseAashka Parikh, Christopher Vinnard, Nicole Fahrenfeld, et al.
Tuberculosis (Edinburgh, Scotland)|November 14, 2022
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations studyKrina Mehta, Navaneeth Narayanan, Scott K Heysell, et al.
Pageof 5